Microsol

Where innovation meets precision in respiratory drug delivery

  • Biotech
Therapeutics

Member

Active

Status

2022

Founded

Development stage

  • No items found.

Microsol is accelerating the development of orally inhaled and nasal drug products. By combining cutting-edge measurement capabilities with advanced predictive simulations, its formulation technology solutions modulate aerosol dynamics and optimise performance. Its highly scalable software enables computational screenings of formulations, increasing throughput and allowing laboratory studies to focus on the most promising candidates.

Founding team

Key contacts